Oxaliplatin improves survival in stage III CRC patients aged 70 years or younger, but not in older patients or those with stage II disease. Patients aged more than 70 years receiving oxaliplatin face ...
For many years, the standard treatment for stage III colon cancer has been surgical resection followed by 5-fluorouracil in combination with folinic acid (5-FU/LV). Ongoing clinical trial evidence ...
Recently, shortening the duration of oxaliplatin-based adjuvant therapy, according to the IDEA collaboration, has led to similar outcomes with an improved burden of toxicity. In a pooled analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results